Published in Clin Res Cardiol on August 23, 2007
Sirolimus-eluting stents in the treatment of chronic total coronary occlusions: results from the prospective multi-center German Cypher Stent Registry. Clin Res Cardiol (2007) 0.85
Short- and long-term effects of a novel paclitaxel coated stent in the porcine coronary model. Clin Res Cardiol (2007) 0.80
The 'all comer' Coroflex Please drug-eluting stent registry in Europe and Asia - an overall and transcontinental assessment of the 10-month major adverse cardiac events. Indian Heart J (2012) 0.78
Adherence to dual antiplatelet therapy after coronary stenting: a systematic review. Clin Cardiol (2014) 0.75
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med (2003) 13.29
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med (2004) 11.86
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA (2005) 9.81
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet (2007) 7.61
Paclitaxel (taxol) N Engl J Med (1995) 5.79
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med (2007) 5.37
Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents. Circulation (2007) 4.71
Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J (2006) 4.38
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med (2005) 3.60
Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol (2005) 3.38
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation (2004) 3.23
Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation (2003) 3.22
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation (2006) 3.08
Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol (2005) 2.90
Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation (1997) 2.76
Distribution of microtubule organizing centers in migrating sheets of endothelial cells. J Cell Biol (1981) 2.51
Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA (2006) 2.06
Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol (2005) 2.00
Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation (2001) 1.86
Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol (2005) 1.73
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis. J Am Coll Cardiol (2005) 1.72
Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare metal stents after a 6-month implantation. Eur Heart J (2006) 1.69
Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA (2005) 1.57
Local drug delivery: impact of pressure, substance characteristics, and stenting on drug transfer into the arterial wall. Catheter Cardiovasc Interv (1999) 1.44
Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation (2006) 1.28
Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest (1995) 1.18
Allergic reactions after the implantation of drug-eluting stents: is it the pill or the polymer? J Am Coll Cardiol (2005) 1.18
Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature. Clin Res Cardiol (2006) 1.07
Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years. J Am Coll Cardiol (2007) 0.99
Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions. Clin Res Cardiol (2006) 0.95
Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation (2005) 0.88
CAAS. II: A second generation system for off-line and on-line quantitative coronary angiography. Cathet Cardiovasc Diagn (1994) 0.87
How to revascularize patients with diabetes mellitus: bypass or stents and drugs? Clin Res Cardiol (2006) 0.87
The paclitaxel-eluting Coroflex Please stent pilot study (PECOPS I): acute and 6-month clinical and angiographic follow-up. Catheter Cardiovasc Interv (2006) 0.83
[Stent therapy with diabetic patients who have coronary artery disease]. Clin Res Cardiol (2006) 0.76
Delayed neointimal healing after drug-eluting stent implantation: seeing is believing. Eur Heart J (2006) 0.75
Induction of interleukin-1 and tumor necrosis factor during in vitro hemodialysis with different membranes. Contrib Nephrol (1989) 0.75
[Paclitaxel: a chemotherapeutic agent for prevention of restenosis? Experimental studies in vitro and in vivo]. Z Kardiol (2000) 0.75
A randomized animal study evaluating the efficacies of locally delivered heparin and urokinase for reducing in-stent restenosis. Coron Artery Dis (1997) 0.75
Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med (2006) 4.07
Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation (2004) 3.76
A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci U S A (2007) 2.60
Randomized, controlled evaluation of a prototype informed consent process for HIV vaccine efficacy trials. J Acquir Immune Defic Syndr (2003) 2.60
Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail (2006) 2.33
Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol (2008) 2.31
Interdisciplinary expert consensus document on management of type B aortic dissection. J Am Coll Cardiol (2013) 2.24
Early detection of mechanical valve dysfunction using a new home monitoring device. Ann Thorac Surg (2007) 2.18
Depression in athletes: prevalence and risk factors. Curr Sports Med Rep (2015) 2.15
Scanning electron microscopic analysis of different drug eluting stents after failed implantation: from nearly undamaged to major damaged polymers. Catheter Cardiovasc Interv (2010) 2.10
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation (2009) 2.09
Erasure of histone acetylation by Arabidopsis HDA6 mediates large-scale gene silencing in nucleolar dominance. Genes Dev (2006) 1.92
Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur J Heart Fail (2009) 1.91
Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 1.83
Recommendations for the management of prosthetic valve thrombosis. J Heart Valve Dis (2005) 1.79
Sleep-disordered breathing in patients with atrial fibrillation and normal systolic left ventricular function. Dtsch Arztebl Int (2009) 1.74
Effect of cardiac resynchronization therapy on global and regional oxygen consumption and myocardial blood flow in patients with non-ischaemic and ischaemic cardiomyopathy. Eur Heart J (2004) 1.73
Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg (2007) 1.61
Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial. EuroIntervention (2011) 1.58
Improvement of cardiac function by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction. Circ J (2011) 1.55
Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients. J Am Coll Cardiol (2012) 1.54
Percutaneous closure of atrial septal defects: echocardiographic and functional results in patients older than 60 years. Circ Cardiovasc Interv (2009) 1.54
Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures. Am Heart J (2009) 1.54
A stochastic biomechanical model for risk and risk factors of non-contact anterior cruciate ligament injuries. J Biomech (2009) 1.54
Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: two-year angiographic and three-year clinical results from the SPIRIT II study. Catheter Cardiovasc Interv (2010) 1.51
Treatment of Cheyne-Stokes respiration reduces arrhythmic events in chronic heart failure. J Cardiovasc Electrophysiol (2013) 1.49
Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis First-in-Man (PEPPER) trial. Cardiovasc Revasc Med (2012) 1.48
Cytomegalovirus infection status predicts progression of heart-transplant vasculopathy. Transplantation (2003) 1.48
Percutaneous vs surgical repair of mitral valve regurgitation: single institution early and midterm outcomes. Can J Cardiol (2012) 1.48
A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial. EuroIntervention (2006) 1.46
Adaptive servoventilation improves cardiac function in patients with chronic heart failure and Cheyne-Stokes respiration. Eur J Heart Fail (2008) 1.45
Vitronectin concentrations predict risk in patients undergoing coronary stenting. Circ Cardiovasc Interv (2008) 1.44
A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. EuroIntervention (2005) 1.42
Prospective relation between catastrophizing and residual pain following knee arthroplasty: two-year follow-up. Pain Res Manag (2008) 1.42
Reoperation of the aortic valve in octogenarians. Ann Thorac Surg (2006) 1.42
Implications of revised AASM rules on scoring apneic and hypopneic respiratory events in patients with heart failure with nocturnal Cheyne-Stokes respiration. Sleep Breath (2014) 1.41
Cardiac resynchronization therapy: long-term alternative to cardiac transplantation? Ann Thorac Surg (2009) 1.41
Pulmonary capillary wedge pressure and pulmonary arterial pressure in heart failure patients with sleep-disordered breathing. Sleep Med (2009) 1.40
Allocation of scarce resources: assessment and impact. Can J Surg (2002) 1.40
Guidelines for the prevention of infective endocarditis revised: a critical appraisal of the AHA recommendations and call for an individual approach. J Heart Valve Dis (2009) 1.40
Non-invasive coronary angiography: the clinical value of multi-slice computed tomography in the assessment of patients with prior coronary bypass surgery. Evaluating grafts and native vessels. Int J Cardiovasc Imaging (2008) 1.40
Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women. Osteoporos Int (2004) 1.39
US-style creationism spreads to Europe. Curr Biol (2002) 1.38
Is routine ultrasound guidance really necessary for closure of patent foramen ovale using the Amplatzer PFO occluder? Catheter Cardiovasc Interv (2009) 1.38
Early (three-month) results of percutaneous mitral valvotomy with the Inoue balloon in 1,123 consecutive patients comparing various age groups. Am J Cardiol (2002) 1.38
Case-crossover study of partner and situational factors for unprotected sex. J Acquir Immune Defic Syndr (2002) 1.29
Safety and acceptability of the Reality condom for anal sex among men who have sex with men. AIDS (2003) 1.28
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol (2010) 1.27
Systematic review of clinical outcomes in hybrid procedures for aortic arch dissections and other arch diseases. J Thorac Cardiovasc Surg (2012) 1.21
Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy. Coron Artery Dis (2008) 1.19
Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res Cardiol (2008) 1.18
Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol (2003) 1.17
Adaptive servoventilation improves cardiac function and respiratory stability. Clin Res Cardiol (2010) 1.15
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. Am J Cardiol (2007) 1.09
Duplicated ectopic ureter with vaginal insertion: 3D CT urography with i.v. and percutaneous contrast administration. AJR Am J Roentgenol (2007) 1.08
Thromboembolic and bleeding complications following St. Jude Medical valve replacement: results of the German Experience With Low-Intensity Anticoagulation Study. Chest (2005) 1.07
Significant obstruction of the right and left ventricular outflow tract in a patient with biventricular hypertrophic cardiomyopathy. Eur J Echocardiogr (2008) 1.07
Central respiratory rhythmogenesis is abnormal in lbx1- deficient mice. J Neurosci (2008) 1.07
Technique of interventional repair in adult aortic coarctation. J Vasc Surg (2010) 1.06
Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. JAMA (2006) 1.06
Provisional extension to induce complete attachment after stent-graft placement in type B aortic dissection: the PETTICOAT concept. J Endovasc Ther (2006) 1.05
Two-dimensional strain and strain rate imaging of the right ventricle in adult patients before and after percutaneous closure of atrial septal defects. Eur J Echocardiogr (2009) 1.05
Primary malignant pericardial mesothelioma - a rare cause of pericardial effusion and consecutive constrictive pericarditis: a case report. J Med Case Rep (2009) 1.05
Cheyne-Stokes respiration in heart failure: cycle length is dependent on left ventricular ejection fraction. Sleep Med (2010) 1.04
Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience. Eur J Echocardiogr (2004) 1.03
Complex sleep apnoea in congestive heart failure. Thorax (2011) 1.02
Use of four MitraClip devices in a patient with ischemic cardiomyopathy and mitral regurgitation: "zipping by clipping". Catheter Cardiovasc Interv (2012) 1.01
Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc Interv (2012) 1.01
23S rDNA real-time polymerase chain reaction of heart valves: a decisive tool in the diagnosis of infective endocarditis. Eur Heart J (2010) 1.00
Indication for percutaneous aortic valve implantation. Arch Med Sci (2010) 1.00
Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis. Clin Chim Acta (2005) 1.00
Comparison of osteoblast spreading on microstructured dental implant surfaces and cell behaviour in an explant model of osseointegration. A scanning electron microscopic study. Clin Oral Implants Res (2005) 0.98
Sleep apnea is common in patients with coronary artery disease. Wien Med Wochenschr (2010) 0.96
Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing. Eur J Heart Fail (2007) 0.96
Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial. Circulation (2004) 0.96
[Heart diseases in pregnancy]. Clin Res Cardiol (2008) 0.96
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study. EuroIntervention (2012) 0.96
Pulse transit time: validation of blood pressure measurement under positive airway pressure ventilation. Sleep Breath (2011) 0.95
Cardiac efficiency and oxygen consumption measured with 11C-acetate PET after long-term cardiac resynchronization therapy. J Nucl Med (2006) 0.95
An unusual bacterium, Aerococcus viridans, and four cases of infective endocarditis. J Heart Valve Dis (2005) 0.95
Antibiotics in crisis. Curr Biol (2013) 0.95
Platelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus type 2. Arterioscler Thromb Vasc Biol (2005) 0.94
Riding the wave of biological data. Curr Biol (2011) 0.94
Comparison of Portapres non-invasive blood pressure measurement in the finger with intra-aortic pressure measurement during incremental bicycle exercise. Blood Press Monit (2002) 0.93
Evaluation of longitudinal and radial left ventricular function by two-dimensional speckle-tracking echocardiography in a large cohort of normal probands. Int J Cardiovasc Imaging (2010) 0.93
A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis. J Mol Med (Berl) (2005) 0.93
Current role of endovascular therapy in Marfan patients with previous aortic surgery. Vasc Health Risk Manag (2008) 0.93